Reuters - A pioneering cannabis-based drug will be
considered by Canadian regulators for approval as a treatment
for cancer pain, its British developer GW Pharmaceuticals Plc
said on Tuesday.
Source: http://rss.news.yahoo.com
Tuesday, June 19, 2007
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment